RICHMOND, Va.--(BUSINESS WIRE)--Altria Group, Inc. (Altria) (NYSE: MO) announces today that the U.S. Food and Drug Administration (FDA) authorized commercialization of the next generation of the IQOS ...

Please provide your email address to receive an email when new articles are posted on . A new battle in the decades-long war between tobacco companies and health advocates recently began when the FDA ...

Philip Morris International presented information on its heat-not-burn tobacco product, iQOS, to an independent advisory committee this week. If the FDA approves iQOS, Altria would receive sole ...

A glass-walled bastion of minimalism in a retail mall in Atlanta is the first of its kind in the United States. It looks like an Apple Store, but with a bouncer. You have to be 21 or older to enter.

Although it is expecting some country-specific headwinds, CEO Andre Calantzopoulos said in a statement, "We enter 2020 with favorable momentum, and expect to deliver like-for-like currency-neutral net ...

The FDA cleared iQOS, Philip Morris International's device to heat tobacco. Altria will sell iQOS in the U.S., with plans to introduce it in Atlanta this summer. iQOS heats tobacco rather than burning ...

The Food and Drug Administration cleared Philip Morris International’s IQOS — a heat-not-burn tobacco device designed as an alternative to conventional cigarettes — for sale in the United States. The ...

An electronic tobacco device may now hit the US market after getting a green light from the US Food and Drug Administration, the agency announced Tuesday. The agency made clear that it has not deemed ...

IQOS 3 offers several enhancements to the IQOS 2.4 currently being sold in select U.S. markets, including a longer battery life, faster re-charging time, a side opening mechanism, and magnetic closure ...